9 results
8-K
EX-1.1
VKTX
Viking Therapeutics Inc
1 Mar 24
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
4:05pm
no security breach or incident, unauthorized access or disclosure, or other compromise of or relating to the Company’s or its subsidiaries … in, any security breach or incident, unauthorized access or disclosure or other compromise to their IT Systems and Data; and (iii) the Company and its
8-K
EX-3.1
VKTX
Viking Therapeutics Inc
11 May 23
Amendments to Articles of Incorporation or Bylaws
5:00pm
. The Chief Executive Officer shall perform other duties commonly incident to the office and shall also perform such other duties and have such other powers … duties commonly incident to the office and shall also perform such other duties and have such other powers as the Board shall designate from time
8-K
EX-1.1
VKTX
Viking Therapeutics Inc
31 Mar 23
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
5:27pm
) Except as described in the Pricing Disclosure Package or the Registration Statement, there has been no security breach or incident, unauthorized access … of, and have no knowledge of any event or condition that would reasonably be expected to result in, any security breach or incident, unauthorized
8-K
EX-10.1
g6c2lwfqx 0ubx4fiyz
2 Aug 19
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
qo537f
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am
8-K
EX-1.1
5vfnoma5yjo5udoe76
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm
- Prev
- 1
- Next